Abstract
Abstract This review explores the enigmatic heart failure (HF) subtype known as HF with mildly reduced ejection fraction (HFmrEF), which constitutes a significant percentage of HF cases yet remains inadequately understood. Characterized by an ejection fraction (EF) between 41% and 49%, HFmrEF poses unique challenges in diagnosis and treatment due to its intermediary nature between HF with reduced EF (HFrEF) and HF with preserved EF (HFpEF). Epidemiological data reveal variable prevalence rates influenced by demographic and regional factors, with a higher incidence associated with aging and cardiovascular comorbidities such as hypertension and diabetes. Pathophysiological insights suggest a blend of systolic and diastolic dysfunction, myocardial fibrosis, and inflammatory processes that differentiate HFmrEF from other HF categories. Diagnostic approaches currently rely on echocardiography and biomarkers such as N-terminal pro-brain natriuretic peptide, but there is a need for more precise tools. Treatment largely extrapolates from HFrEF and HFpEF protocols, yet specific evidence for HFmrEF is sparse, underscoring the necessity for targeted clinical trials. Patient outcomes, falling between those of HFrEF and HFpEF, further highlight the need for individualized management strategies. This review underscores the urgency of dedicated research to refine diagnostic criteria, optimize therapeutic regimens, and ultimately improve patient care for those with HFmrEF. Future research must focus on tailored treatments, pathophysiological clarity, and identifying specific biomarkers to advance our understanding and management of this complex condition.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
